FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Allen Kaplan

Research Profile

Chemicals & Drugs

Anatomy

Physiology

Histamine Release

Disorders

Concepts & Ideas

Molecular Weight

Co-author Network

Publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Allen Kaplan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Allen P Kaplan
Treatment of chronic spontaneous urticaria.
Allergy, asthma & immunology research 2012;4(6):326-31.
2012: Allen P Kaplan
Biologic agents in the treatment of urticaria.
Current allergy and asthma reports 2012;12(4):288-91.
2011: Allen P Kaplan
History of the World Allergy Organization: 1989 to 2006, the XVIII World Allergy Congress, Journal Development, Reorganization, and New Programs.
The World Allergy Organization journal 2011;4(8):135-7.
2011: Allen P Kaplan
What to do with refractory urticaria patients.
Current allergy and asthma reports 2011;11(3):189-91.
2011: Allen P Kaplan
Bradykinin and the pathogenesis of hereditary angioedema.
The World Allergy Organization journal 2011;4(4):73-5.
2010: Allen P Kaplan
Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy.
The Journal of allergy and clinical immunology 2010;126(5):918-25.
2010: Allen P Kaplan; Berhane Ghebrehiwet
The plasma bradykinin-forming pathways and its interrelationships with complement.
Molecular immunology 2010;47(13):2161-9.
2010: Allen P Kaplan
Treatment of cold urticaria.
Current allergy and asthma reports 2010;10(4):223-4.
2010: Allen P Kaplan
Dietary therapy for chronic urticaria.
Current allergy and asthma reports 2010;10(4):225-6.
2010: Allen P Kaplan; Kusumam Joseph
Kinin formation in C1 inhibitor deficiency.
The Journal of allergy and clinical immunology 2010;125(6):1411-2; author reply 1412.
2010: Allen P Kaplan; Kusumam Joseph
The bradykinin-forming cascade and its role in hereditary angioedema.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2010;104(3):193-204.
2010: Allen P Kaplan
Kinins, airway obstruction, and anaphylaxis.
Chemical immunology and allergy 2010;95():67-84.
2010: Kusumam Joseph; Tracy E Tholanikunnel; Allen P Kaplan
Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2010;104(1):50-4.
2009: Kusumam Joseph; Baby G Tholanikunnel; Allen P Kaplan
Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
The Journal of allergy and clinical immunology 2009;124(1):143-9.
2009: Allen P Kaplan; M Greaves
Pathogenesis of chronic urticaria.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2009;39(6):777-87.
2009: Allen P Kaplan
What the first 10,000 patients with chronic urticaria have taught me: a personal journey.
The Journal of allergy and clinical immunology 2009;123(3):713-7.
2008: Kusumam Joseph; Thomson B Tuscano; Allen P Kaplan
Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2008;101(3):279-86.
2008: Allen P Kaplan; Kusumam Joseph; Robert J Maykut; Gregory P Geba; Robert K Zeldin
Treatment of chronic autoimmune urticaria with omalizumab.
The Journal of allergy and clinical immunology 2008;122(3):569-73.
2007: Allen P Kaplan; Kusumam Joseph
Basophil secretion in chronic urticaria: autoantibody-dependent or not?
The Journal of allergy and clinical immunology 2007;120(3):729-30.
2007: Bradford A Woodworth; Jeffrey G Neal; Danforth Newton; Kusumam Joseph; Allen P Kaplan; John E Baatz; Rodney J Schlosser
Surfactant protein A and D in human sinus mucosa: a preliminary report.
ORL; journal for oto-rhino-laryngology and its related specialties 2007;69(1):57-60.
2005: Allen P Kaplan; Malcolm W Greaves
Angioedema.
Journal of the American Academy of Dermatology 2005;53(3):373-88; quiz 389-92.
2005: Anthony N Fernando; Lawrence P Fernando; Yu Fukuda; Allen P Kaplan
Assembly, activation, and signaling by kinin-forming proteins on human vascular smooth muscle cells.
American journal of physiology. Heart and circulatory physiology 2005;289(1):H251-7.
2005: Allen P Kaplan; Sheldon L Spector; Suzanne Meeves; Yuning Liao; Santosh T Varghese; George Georges
Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2005;94(6):662-9.
2005: A M Marsland; Sridharan Soundararajan; Kusumam Joseph; Allen P Kaplan
Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2005;35(5):554-9.
2005: Allen P Kaplan; Berhane Ghebrehiwet
Does C-2 kinin exist?
The Journal of allergy and clinical immunology 2005;115(4):876.
2005: Sridharan Soundararajan; Yoko Kikuchi; Kusumam Joseph; Allen P Kaplan
Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria.
The Journal of allergy and clinical immunology 2005;115(4):815-21.
2005: Allen P Kaplan
A new mechanism for immunologic initiation of asthma.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(5):1267-8.
2005: Kusumam Joseph; Allen P Kaplan
Formation of bradykinin: a major contributor to the innate inflammatory response.
Advances in immunology 2005;86():159-208.
2004: Bradford A Woodworth; Kusumam Joseph; Allen P Kaplan; Rodney J Schlosser
Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2004;131(5):585-9.
2004: Allen P Kaplan
Chronic urticaria: pathogenesis and treatment.
The Journal of allergy and clinical immunology 2004;114(3):465-74; quiz 475.
2004: Kusumam Joseph; Baby G Tholanikunnel; Berhane Ghebrehiwet; Allen P Kaplan
Interaction of high molecular weight kininogen binding proteins on endothelial cells.
Thrombosis and haemostasis 2004;91(1):61-70.
2003: Lawrence P Fernando; Anthony N Fernando; Kusumam Joseph; Allen P Kaplan
Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells.
Journal of thrombosis and haemostasis : JTH 2003;1(11):2444-9.
2003: Lawrence P Fernando; Snehlatha Natesan; Kusumam Joseph; Allen P Kaplan
High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
Thrombosis and haemostasis 2003;90(5):787-95.
2002: Yoshitaka Nakazawa; Kusumam Joseph; Allen P Kaplan
Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5.
International immunopharmacology 2002;2(13-14):1875-85.
2002: Kusumam Joseph; Baby G Tholanikunnel; Allen P Kaplan
Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90.
International immunopharmacology 2002;2(13-14):1851-9.
2002: Allen P Kaplan
Chronic urticaria--new concepts regarding pathogenesis and treatment.
Current allergy and asthma reports 2002;2(4):263-4.
2002: Allen P Kaplan; Kusumam Joseph; Michael Silverberg
Pathways for bradykinin formation and inflammatory disease.
The Journal of allergy and clinical immunology 2002;109(2):195-209.
2002: Kusumam Joseph; Baby G Tholanikunnel; Allen P Kaplan
Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(2):896-900.
2002: Allen P Kaplan
Clinical practice. Chronic urticaria and angioedema.
The New England journal of medicine 2002;346(3):175-9.
2002: SP Commins; Allen P Kaplan
Immediate pressure urticaria.
Allergy 2002;57(1):56-7.
2002: Yoko Kikuchi; Allen P Kaplan
A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria.
The Journal of allergy and clinical immunology 2002;109(1):114-8.
2001: Yoko Kikuchi; Allen P Kaplan
Mechanisms of autoimmune activation of basophils in chronic urticaria.
The Journal of allergy and clinical immunology 2001;107(6):1056-62.
2001: Allen P Kaplan
Chemokines, chemokine receptors and allergy.
International archives of allergy and immunology 2001;124(4):423-31.
2001: Allen P Kaplan
C1 inhibitor deficiency: hereditary and acquired forms.
Journal of investigational allergology & clinical immunology : official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología 2001;11(4):211-9.
2001: Allen P Kaplan; Kusumam Joseph; Y Shibayama; SR Reddigari; Berhane Ghebrehiwet
Activation of the plasma kinin forming cascade along cell surfaces.
International archives of allergy and immunology 2001;124(1-3):339-42.
2001: Kusumam Joseph; Berhane Ghebrehiwet; Allen P Kaplan
Activation of the kinin-forming cascade on the surface of endothelial cells.
Biological chemistry 2001;382(1):71-5.
2001: Kusumam Joseph; Y Shibayama; Berhane Ghebrehiwet; Allen P Kaplan
Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.
Thrombosis and haemostasis 2001;85(1):119-24.
2000: Allen P Kaplan
Diagnostic tests for urticaria and angioedema.
Clinical allergy and immunology 2000;15():111-26.
1999: Kusumam Joseph; Y Shibayama; Yoshitaka Nakazawa; Ellinor I B Peerschke; Berhane Ghebrehiwet; Allen P Kaplan
Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease.
Immunopharmacology 1999;43(2-3):203-10.
1999: Kusumam Joseph; Berhane Ghebrehiwet; Allen P Kaplan
Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells.
Clinical immunology (Orlando, Fla.) 1999;92(3):246-55.
1999: Kusumam Joseph; Yoshitaka Nakazawa; W F Bahou; Berhane Ghebrehiwet; Allen P Kaplan
Platelet glycoprotein Ib: a zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen.
Molecular medicine (Cambridge, Mass.) 1999;5(8):555-63.
1999: M Ferrer; K Nakazawa; Allen P Kaplan
Complement dependence of histamine release in chronic urticaria.
The Journal of allergy and clinical immunology 1999;104(1):169-72.
1999: Y Shibayama; Kusumam Joseph; Yoshitaka Nakazawa; B Ghebreihiwet; Ellinor I B Peerschke; Allen P Kaplan
Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein.
Clinical immunology (Orlando, Fla.) 1999;90(1):89-99.
1998: M Ferrer; J P Kinét; Allen P Kaplan
Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria.
The Journal of allergy and clinical immunology 1998;101(5):672-6.
1998: Y Shibayama; SR Reddigari; M Teruya; K Nakamura; Y Fukunaga; K Ienaga; K Nishikawa; S Suehiro; Allen P Kaplan
Effect of neurotropin on the binding of high molecular weight kininogen and Hageman factor to human umbilical vein endothelial cells and the autoactivation of bound Hageman factor.
Biochemical pharmacology 1998;55(8):1175-80.
1998: Allen P Kaplan; Kusumam Joseph; Y Shibayama; Yoshitaka Nakazawa; Berhane Ghebrehiwet; SR Reddigari; Michael Silverberg
Bradykinin formation. Plasma and tissue pathways and cellular interactions.
Clinical reviews in allergy & immunology 1998;16(4):403-29.
1998: Allen P Kaplan; Piotr Kuna
Chemokines and the late-phase reaction.
Allergy 1998;53(45 Suppl):27-32.
1997: Allen P Kaplan; Kusumam Joseph; Y Shibayama
Binding of activation of kinin-forming proteins on vascular endothelial cells.
Immunopharmacology 1997;36(2-3):201-7.
1997: T Brunnée; SR Reddigari; Y Shibayama; Allen P Kaplan; Michael Silverberg
Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1997;27(6):653-63.
1997: L J Tong; G Balakrishnan; J P Kochan; J P Kinét; Allen P Kaplan
Assessment of autoimmunity in patients with chronic urticaria.
The Journal of allergy and clinical immunology 1997;99(4):461-5.
1997: Allen P Kaplan; Kusumam Joseph; Y Shibayama; SR Reddigari; Berhane Ghebrehiwet; Michael Silverberg
The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation.
Advances in immunology 1997;66():225-72.
1996: Kusumam Joseph; Berhane Ghebrehiwet; Ellinor I B Peerschke; Kenneth B M Reid; Allen P Kaplan
Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
Proceedings of the National Academy of Sciences of the United States of America 1996;93(16):8552-7.
1996: Piotr Kuna; SR Reddigari; D Rucinski; Allen P Kaplan
Further characterization of histamine releasing chemokines present in fractionated supernatants derived from human mononuclear cells.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1996;26(8):926-33.
1996: Y Shibayama; SR Reddigari; Allen P Kaplan
Interactions of factor XII with platelets and endothelial cells.
Immunopharmacology 1996;32(1-3):24-7.
1996: Piotr Kuna; M Lazarovich; Allen P Kaplan
Chemokines in seasonal allergic rhinitis.
The Journal of allergy and clinical immunology 1996;97(1 Pt 1):104-12.
1995: Allen P Kaplan; Piotr Kuna; SR Reddigari
Chemokines and the allergic response.
Experimental dermatology 1995;4(4 Pt 2):260-5.
1995: SR Reddigari; Michael Silverberg; Allen P Kaplan
Assembly of the human plasma kinin-forming cascade along the surface of vascular endothelial cells.
International archives of allergy and immunology 1995;107(1-3):93-4.
1995: Piotr Kuna; SR Reddigari; D Rucinski; T J Schall; Allen P Kaplan
Chemokines of the alpha, beta-subclass inhibit human basophils' responsiveness to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1.
The Journal of allergy and clinical immunology 1995;95(2):574-86.
1994: Allen P Kaplan; Piotr Kuna; SR Reddigari
Chemokines as allergic mediators--relationship to histamine-releasing factors.
Allergy 1994;49(7):495-501.
1993: SR Reddigari; Y Shibayama; T Brunnée; Allen P Kaplan
Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.
The Journal of biological chemistry 1993;268(16):11982-7.
1993: SR Reddigari; Piotr Kuna; G Miragliotta; Y Shibayama; K Nishikawa; Allen P Kaplan
Human high molecular weight kininogen binds to human umbilical vein endothelial cells via its heavy and light chains.
Blood 1993;81(5):1306-11.
1993: Piotr Kuna; SR Reddigari; T J Schall; D Rucinski; M Sadick; Allen P Kaplan
Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(5):1932-43.
1993: T Brunnée; C La Porta; SR Reddigari; V M Salerno; Allen P Kaplan; Michael Silverberg
Activation of factor XI in plasma is dependent on factor XII.
Blood 1993;81(3):580-6.
1992: K Nishikawa; Y Shibayama; Piotr Kuna; E Calcaterra; Allen P Kaplan; SR Reddigari
Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein.
Blood 1992;80(8):1980-8.
1992: Piotr Kuna; SR Reddigari; T J Schall; D Rucinski; MICHAEL VIKSMAN; Allen P Kaplan
RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(2):636-42.
1992: K Nishikawa; SR Reddigari; Michael Silverberg; Piotr Kuna; Hisashi Yago; Y Nagaki; Y Toyomaki; S Suehiro; Allen P Kaplan
Effect of Neurotropin on the activation of the plasma kallikrein-kinin system.
Biochemical pharmacology 1992;43(6):1361-9.
1992: SR Reddigari; Piotr Kuna; G F Miragliotta; D Kornfeld; M L Baeza; C William Castor; Allen P Kaplan
Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
The Journal of allergy and clinical immunology 1992;89(3):666-72.
1992: Piotr Kuna; SR Reddigari; D Rucinski; J J Oppenheim; Allen P Kaplan
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils.
The Journal of experimental medicine 1992;175(2):489-93.
1992: Allen P Kaplan; SR Reddigari; T Brunnée; K Nishikawa; Piotr Kuna; Michael Silverberg
Studies of the activation and inhibition of the plasma kallikrein-kinin system.
Agents and actions. Supplements 1992;38 ( Pt 3)():317-28.
1991: Piotr Kuna; SR Reddigari; D Kornfeld; Allen P Kaplan
IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(6):1920-4.
1991: Allen P Kaplan; SR Reddigari; M Baeza; Piotr Kuna
Histamine releasing factors and cytokine-dependent activation of basophils and mast cells.
Advances in immunology 1991;50():237-60.
1991: Allen P Kaplan; M Baeza; SR Reddigari; Piotr Kuna
Histamine-releasing factors.
International archives of allergy and applied immunology 1991;94(1-4):148-53.
1991: Allen P Kaplan; M Baeza; SR Reddigari; Piotr Kuna
Histamine releasing factors.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1991;21 Suppl 1():8-16.
1990: A S Kurtz; Allen P Kaplan
Regional expression of cold urticaria.
The Journal of allergy and clinical immunology 1990;86(2):272-3.
1990: M L Baeza; SR Reddigari; D Kornfeld; N Ramani; E M Smith; PA Hossler; T Fischer; C William Castor; P G Gorevic; Allen P Kaplan
Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III.
The Journal of clinical investigation 1990;85(5):1516-21.
1990: Allen P Kaplan
Urticaria: the relationship of duration of lesion to pathogenesis.
Allergy proceedings : the official journal of regional and state allergy societies 1990;11(1):15-8.
1989: SR Reddigari; Allen P Kaplan
Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity.
Blood 1989;74(2):695-702.
1989: SR Reddigari; Allen P Kaplan
Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody.
Journal of immunological methods 1989;119(1):19-25.
1989: M L Baeza; SR Reddigari; M Haak-Frendscho; Allen P Kaplan
Purification and further characterization of human mononuclear cell histamine-releasing factor.
The Journal of clinical investigation 1989;83(4):1204-10.
1989: I A Sheikh; Allen P Kaplan
Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products.
Biochemical pharmacology 1989;38(6):993-1000.
1989: Allen P Kaplan; M Silverberg; Berhane Ghebrehiwet; P Atkins; B Zweiman
Pathways of kinin formation and role in allergic diseases.
Clinical immunology and immunopathology 1989;50(1 Pt 2):S41-51.
1989: SR Reddigari; Allen P Kaplan
Studies of the cleavage of human high molecular weight kininogen by purified plasma and tissue kallikreins, and upon contact activation of plasma.
Advances in experimental medicine and biology 1989;247B():317-24.
1988: B P Randazzo; H B Fleit; Allen P Kaplan; Berhane Ghebrehiwet
Expression of functional cell surface C1-inactivator by U937 cells.
Clinical immunology and immunopathology 1988;49(3):463-77.
1988: M L Baeza; M Haak-Frendscho; S Satnick; Allen P Kaplan
Responsiveness to human mononuclear cell-derived histamine-releasing factor. Studies of allergic status and the role of IgE.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(8):2688-92.
1988: M Haak-Frendscho; M Sarfati; G Delespesse; Allen P Kaplan
Comparison of mononuclear cell and B-lymphoblastoid histamine-releasing factor and their distinction from an IgE-binding factor.
Clinical immunology and immunopathology 1988;49(1):72-82.
1988: M Haak-Frendscho; C Dinarello; Allen P Kaplan
Recombinant human interleukin-1 beta causes histamine release from human basophils.
The Journal of allergy and clinical immunology 1988;82(2):218-23.
1988: M Haak-Frendscho; N Arai; K Arai; M L Baeza; A Finn; Allen P Kaplan
Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release.
The Journal of clinical investigation 1988;82(1):17-20.
1988: SR Reddigari; Allen P Kaplan
Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma.
Blood 1988;71(5):1334-40.
1985: Allen P Kaplan; M Haak-Frendscho; Anthony Fauci; C Dinarello; E Halbert
A histamine-releasing factor from activated human mononuclear cells.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(3):2027-32.
1985: B P Randazzo; R J Dattwyler; Allen P Kaplan; Berhane Ghebrehiwet
Synthesis of C1 inhibitor (C1-INA) by a human monocyte-like cell line, U937.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(2):1313-9.
1984: Berhane Ghebrehiwet; B P Randazzo; Allen P Kaplan
Studies of complement autoactivatability in hereditary angioedema: direct relationship to functional C-1-INA and the effect of classical pathway activators.
Clinical immunology and immunopathology 1984;32(1):101-10.
1983: Berhane Ghebrehiwet; B P Randazzo; J T Dunn; M Silverberg; Allen P Kaplan
Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.
The Journal of clinical investigation 1983;71(5):1450-6.